Evgeniya Zyablitskaya

Evgeniya Zyablitskaya


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2019 in Molecules
Verified
Journal Article
Open access
PDF file
KLKateryna Laikova
Kateryna Laikova
Vol V. OberemokVol V. Oberemok
Vol V. Oberemok
AKAlisa Krasnodubets
Alisa Krasnodubets
Nikita V. Gal'chinskyNikita V. Gal'chinsky
Nikita V. Gal'chinsky
RURefat Zhevdetovich Useinov
Refat Zhevdetovich Useinov
Anatolii V KubyshkinAnatolii V Kubyshkin
Anatolii V Kubyshkin
Skin cancer has always been and remains the leader among all tumors in terms of occurrence. One of the main factors responsible for skin cancer, natural and artificial UV radiation, causes the mutations that transform healthy cells into cancer cells. These mutations inactivate apoptosis, an event required to avoid the malignant transformation of healthy cells. Among these deadliest of cancers, melanoma and its ‘younger sister’, Merkel cell carcinoma, are the most lethal. The heavy toll of skin cancers stems from their rapid progression and the fact that they metastasize easily. Added to this is the difficulty in determining reliable margins when excising tumors and the lack of effective chemotherapy. Possibly the biggest problem posed by skin cancer is reliably detecting the extent to which cancer cells have spread throughout the body. The initial tumor is visible and can be removed, whereas metastases are invisible to the naked eye and much harder to eliminate. In our opinion, antisense oligonucleotides, which can be used in the form of targeted ointments, provide real hope as a treatment that will eliminate cancer cells near the tumor focus both before and after surgery.

5 June 2023 in Koloproktologia
Verified
Journal Article
Open access
PDF file
PMP. E. Maksimova
P. E. Maksimova
EGE. P. Golubinskaya
E. P. Golubinskaya
BSB. D. Seferov
B. D. Seferov
EZEvgeniya Zyablitskaya
Evgeniya Zyablitskaya
ЕЗЕ. Ю. Зяблицкая
Е. Ю. Зяблицкая
This article analyzes the statistical data on colorectal cancer in Russia and in the world, including incidence, mortality and survival. The main pathways of colorectal cancer carcinogenesis, molecular subtypes and their influence on the difference in lesions of the proximal and distal large intestine are presented. The paper provides an overview of the leading chemotherapy agents and targeted therapy in colorectal cancer, as well as the main reasons for the development of therapeutic resistance, including changes in the cellular microenvironment of the tumor.

14 June 2023 in Molecular Cancer Research
Verified
Journal Article
Closed access
PDF file
AMAmanda Macke
Amanda Macke
APArtem N. Pachikov
Artem N. Pachikov
TDTaylor E. Divita
Taylor E. Divita
MMMary E. Morris
Mary E. Morris
CLChad A. LaGrange
Chad A. LaGrange
APArmen Petrosyan
Armen Petrosyan
Prostate cancer progression to the lethal metastatic castration-resistant phenotype (mCRPC) is driven by αv integrins and is associated with Golgi disorganization and activation of the ATF6 branch of unfolded protein response (UPR). Overexpression of integrins requires N-acetylglucosaminyltransferase-V (MGAT5)-mediated glycosylation and subsequent cluster formation with Galectin-3 (Gal-3). However, the mechanism underlying this altered glycosylation is missing. For the first time, using HALO analysis of IHC, we found a strong association of integrin αv and Gal-3 at the plasma membrane (PM) in primary prostate cancer and mCRPC samples. We discovered that MGAT5 activation is caused by Golgi fragmentation and mislocalization of its competitor, N-acetylglucosaminyltransferase-III, MGAT3, from Golgi to the endoplasmic reticulum (ER). This was validated in an ethanol-induced model of ER stress, where alcohol treatment in androgen-refractory PC-3 and DU145 cells or alcohol consumption in patient with prostate cancer samples aggravates Golgi scattering, activates MGAT5, and enhances integrin expression at PM. This explains known link between alcohol consumption and prostate cancer mortality. ATF6 depletion significantly blocks UPR and reduces the number of Golgi fragments in both PC-3 and DU145 cells. Inhibition of autophagy by hydroxychloroquine (HCQ) restores compact Golgi, rescues MGAT3 intra-Golgi localization, blocks glycan modification via MGAT5, and abrogates delivery of Gal-3 to the cell surface. Importantly, the loss of Gal-3 leads to reduced integrins at PM and their accelerated internalization. ATF6 depletion and HCQ treatment synergistically decrease integrin αv and Gal-3 expression and temper orthotopic tumor growth and metastasis. Implications: Combined ablation of ATF6 and autophagy can serve as new mCRPC therapeutic.

Verified
Journal Article
Open access
PDF file
TMTatyana Makalish
Tatyana Makalish
IGIlya Golovkin
Ilya Golovkin
Vol V. OberemokVol V. Oberemok
Vol V. Oberemok
KLKateryna Laikova
Kateryna Laikova
ZTZenure Temirova
Zenure Temirova
Anatolii V KubyshkinAnatolii V Kubyshkin
Anatolii V Kubyshkin
The urgency of the search for inexpensive and effective drugs with localized action for the treatment of rheumatoid arthritis continues unabated. In this study, for the first time we investigated the Cytos-11 antisense oligonucleotide suppression of TNF-α gene expression in a rat model of rheumatoid arthritis induced by complete Freund’s adjuvant. Cytos-11 has been shown to effectively reduce peripheral blood concentrations of TNF-α, reduce joint inflammation, and reduce pannus development. The results achieved following treatment with the antisense oligonucleotide Cytos-11 were similar to those of adalimumab (Humira®); they also compared favorably with those results, which provides evidence of the promise of drugs based on antisense technologies in the treatment of this disease.

5 September 2020 in Journal of Diabetes & Metabolic Disorders
Verified
Journal Article
Closed access
PDF file
Anatolii V KubyshkinAnatolii V Kubyshkin
Anatolii V Kubyshkin
ASAlina Shevandova
Alina Shevandova
VPVitalina Petrenko
Vitalina Petrenko
IFIrina Fomochkina
Irina Fomochkina
LSLeya Sorokina
Leya Sorokina
IFIvan Fomochkin
Ivan Fomochkin

30 April 2022 in PULMONOLOGIYA
Verified
Journal Article
Closed access
PDF file
IYI. A. Yatskov
I. A. Yatskov
VBV. A. Beloglazov
V. A. Beloglazov
Anatolii V KubyshkinAnatolii V Kubyshkin
Anatolii V Kubyshkin
ANA. P. Nikolaeva
A. P. Nikolaeva
EZEvgeniya Zyablitskaya
Evgeniya Zyablitskaya
ELE. N. Lavrenchu
E. N. Lavrenchu
Although more than 2 years have passed since the beginning of the pandemic of the new coronavirus infection, treatment and prediction of the course of SARS-CoV-2 infection remain pressing global problems. In this regard, the search for additional links in the pathogenesis of SARS-CoV-2 is currently one of the most important tasks. The Aim. To assess the level of lipopolysaccharide-binding protein (LBP) and presepsin (sCD14-ST) in patients with SARS-CoV-2 viral lung disease in Crimea.Methods. We examined 121 patients with a positive PCR result for SARS-CoV-2 in the age group of 45 – 75 years who were hospitalized in the Department of Infectious Diseases, State Budgetary Healthcare Institution of the Republic of Crimea “N.A.Semashko Republican Clinical Hospital”. Patients were divided into 3 clinical groups according to the severity of SARS-CoV-2 infection: Group 1 – patients with moderate disease, Group 2 – patients with severe disease, and Group 3 – patients with fatal outcome. Peripheral blood levels of LBP, presepsin, ferritin, and C-reactive protein were determined upon admission to the infectious disease hospital.Results. A significant increase in all studied parameters was observed in the 1st, 2nd and 3rd clinical groups of patients with coronavirus infection. This finding corresponds to the state of lipopolysaccharide-binding systems and systemic infection in patients with SARS-CoV-2 viral lung disease. The highest levels of LBP, sCD14-ST, and ferritin were registered in the 3rd clinical group. We found a direct correlation between LBP and sCD14-ST levels in the 2nd group (r = 0.523, p < 0.05) and the 3rd group (r = 0.748, p < 0.05).Conclusion. Patients with SARS-CoV-2 lung disease were found to have an increased blood levels of LBP and presepsin upon admission. The highest values were observed in patients with fatal outcome. Severe SARSCoV-2 lung damage was associated with a direct correlation between levels of LBP and sCD14-ST. Presepsin, LBP, and ferritin are important prognostic markers for severe SARS-CoV-2 lung damage and risk of death in the early stages of hospital treatment.